Approvals/TGA/FIRAZYR icatibant (as acetate) 30 mg/3 mL injection pre-filled syringe

Approved

STANDARD

FIRAZYR icatibant (as acetate) 30 mg/3 mL injection pre-filled syringe

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: da818f479b1409cc
Product Name: FIRAZYR icatibant (as acetate) 30 mg/3 mL injection pre-filled syringe
Artg Id: 160313
Artg Name: FIRAZYR icatibant (as acetate) 30 mg/3 mL injection pre-filled syringe
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2010-09-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/773ebdcc12c6555f1029a40da58c1c86.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/be3e04b75a55bfb2de139c2153d8be2d.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

da818f479b1409cc

Type

Standard